Han X, Zhu Y, Ke J, Zhai Y, Huang M, Zhang X
Cell Death Discov. 2024; 10(1):331.
PMID: 39033180
PMC: 11271487.
DOI: 10.1038/s41420-024-02092-2.
Zhang J, Wang R, Klinger F, Cheng S, Shen W, Sun X
Zool Res. 2024; 45(2):415-428.
PMID: 38485509
PMC: 11017081.
DOI: 10.24272/j.issn.2095-8137.2023.236.
Liu S, Xiang D
Front Genet. 2023; 14:1270983.
PMID: 38125749
PMC: 10731383.
DOI: 10.3389/fgene.2023.1270983.
Qi S, Song J, Chen L, Weng H
Mol Med. 2023; 29(1):166.
PMID: 38066436
PMC: 10709953.
DOI: 10.1186/s10020-023-00764-w.
Krejci J, Arcidiacono O, cegan R, Radaszkiewicz K, Pachernik J, Pirk J
Physiol Res. 2023; 72(4):425-444.
PMID: 37795886
PMC: 10634569.
DOI: 10.33549/physiolres.935078.
Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape.
Kong Y, Yu J, Ge S, Fan X
Innovation (Camb). 2023; 4(4):100452.
PMID: 37485079
PMC: 10362524.
DOI: 10.1016/j.xinn.2023.100452.
N-adenosine (mA) mRNA methylation is required for Tribolium castaneum development and reproduction.
Jiao Y, Palli S
Insect Biochem Mol Biol. 2023; 159:103985.
PMID: 37422274
PMC: 10528953.
DOI: 10.1016/j.ibmb.2023.103985.
RNA modifications in hematological malignancies.
Jin Z, MacPherson K, Liu Z, Vu L
Int J Hematol. 2023; 117(6):807-820.
PMID: 36929506
DOI: 10.1007/s12185-023-03576-0.
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
Zhou X, Li C, Chen T, Li W, Wang X, Yang Q
Mol Cancer. 2023; 22(1):36.
PMID: 36810108
PMC: 9942356.
DOI: 10.1186/s12943-023-01746-6.
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.
Fiorentino F, Menna M, Rotili D, Valente S, Mai A
J Med Chem. 2023; 66(3):1654-1677.
PMID: 36692498
PMC: 9923689.
DOI: 10.1021/acs.jmedchem.2c01601.
METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an mG-modified miR-760-dependent manner.
Xie H, Wang M, Yu H, Wang H, Ding L, Wang R
Cell Death Discov. 2022; 8(1):458.
PMID: 36396627
PMC: 9672058.
DOI: 10.1038/s41420-022-01236-6.
Role of N‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review).
Ye T, Wang J, Zhao H, Zhao G, Li P
Int J Oncol. 2022; 62(1).
PMID: 36367195
PMC: 9699722.
DOI: 10.3892/ijo.2022.5452.
Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis.
Wan L, Liu J, Huang C, Zhu Z, Wang K, Sun G
Mediators Inflamm. 2022; 2022:4766992.
PMID: 36330380
PMC: 9626244.
DOI: 10.1155/2022/4766992.
6S RNA complexed to RNA polymerase maintains product RNA synthesis at low cellular ATP levels by initiation with noncanonical initiator nucleotides.
Bonar C, Han J, Wang R, Panchapakesan S, Unrau P
RNA. 2022; 28(12):1643-1658.
PMID: 36198425
PMC: 9670815.
DOI: 10.1261/rna.079356.122.
Analyzing viral epitranscriptomes using nanopore direct RNA sequencing.
Hong A, Kim D, Kim V, Chang H
J Microbiol. 2022; 60(9):867-876.
PMID: 36001233
PMC: 9400574.
DOI: 10.1007/s12275-022-2324-4.
An Interplay between Epigenetics and Translation in Oocyte Maturation and Embryo Development: Assisted Reproduction Perspective.
Dvoran M, Nemcova L, Kalous J
Biomedicines. 2022; 10(7).
PMID: 35884994
PMC: 9313063.
DOI: 10.3390/biomedicines10071689.
Novel insights into mA modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance.
Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J
Int J Biol Sci. 2022; 18(11):4432-4451.
PMID: 35864970
PMC: 9295064.
DOI: 10.7150/ijbs.73093.
RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.
Kumari S, Kumar S, Muthuswamy S
J Cancer Res Clin Oncol. 2022; 149(4):1621-1633.
PMID: 35796777
DOI: 10.1007/s00432-022-04158-z.
Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.
Yang Y, Shuai P, Li X, Sun K, Jiang X, Liu W
BMC Biol. 2022; 20(1):140.
PMID: 35698136
PMC: 9195452.
DOI: 10.1186/s12915-022-01335-x.
[Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y, Fang S, Yang J, Wang H, Jiao Y, Wang N
Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(5):690-697.
PMID: 35673912
PMC: 9178644.
DOI: 10.12122/j.issn.1673-4254.2022.05.09.
